131 related articles for article (PubMed ID: 2169578)
1. Identification of a specific domain in the beta-adrenergic receptor required for phorbol ester-induced inhibition of catecholamine-stimulated adenylyl cyclase.
Johnson JA; Clark RB; Friedman J; Dixon RA; Strader CD
Mol Pharmacol; 1990 Sep; 38(3):289-93. PubMed ID: 2169578
[TBL] [Abstract][Full Text] [Related]
2. Phorbol ester-induced augmentation and inhibition of epinephrine-stimulated adenylate cyclase in S49 lymphoma cells.
Johnson JA; Goka TJ; Clark RB
J Cyclic Nucleotide Protein Phosphor Res; 1986; 11(3):199-215. PubMed ID: 3020100
[TBL] [Abstract][Full Text] [Related]
3. Sensitization of adenylyl cyclase by P2 purinergic and M5 muscarinic receptor agonists in L cells.
Johnson JA; Friedman J; Halligan RD; Birnbaumer M; Clark RB
Mol Pharmacol; 1991 Oct; 40(4):539-46. PubMed ID: 1921986
[TBL] [Abstract][Full Text] [Related]
4. Beta 2-adrenergic receptor mutants reveal structural requirements for the desensitization observed with long-term epinephrine treatment.
Proll MA; Clark RB; Butcher RW
Mol Pharmacol; 1993 Sep; 44(3):569-74. PubMed ID: 8396717
[TBL] [Abstract][Full Text] [Related]
5. Endothelin- and ATP-induced inhibition of adenylyl cyclase activity in C6 glioma cells: role of Gi and calcium.
Lin WW; Chuang DM
Mol Pharmacol; 1993 Jul; 44(1):158-65. PubMed ID: 8341270
[TBL] [Abstract][Full Text] [Related]
6. Phorbol ester-induced inhibition of the beta-adrenergic system in pulmonary endothelium: role of a pertussis toxin-sensitive protein.
Newman KB; Michael JR; Feldman AM
Am J Respir Cell Mol Biol; 1989 Dec; 1(6):517-23. PubMed ID: 2561591
[TBL] [Abstract][Full Text] [Related]
7. Identification of a specific site required for rapid heterologous desensitization of the beta-adrenergic receptor by cAMP-dependent protein kinase.
Clark RB; Friedman J; Dixon RA; Strader CD
Mol Pharmacol; 1989 Sep; 36(3):343-8. PubMed ID: 2550773
[TBL] [Abstract][Full Text] [Related]
8. Involvement of protein kinase C in the UTP-mediated potentiation of cyclic AMP accumulation in mouse J774 macrophages.
Lin WW; Chen BC
Br J Pharmacol; 1997 Aug; 121(8):1749-57. PubMed ID: 9283713
[TBL] [Abstract][Full Text] [Related]
9. Hamster alpha 1B-adrenergic receptor directly activates Gs in the transfected Chinese hamster ovary cells.
Horie K; Itoh H; Tsujimoto G
Mol Pharmacol; 1995 Sep; 48(3):392-400. PubMed ID: 7565618
[TBL] [Abstract][Full Text] [Related]
10. Potent Gi-mediated inhibition of adenylyl cyclase by a phosphonate analog of monooleylphosphatidate.
Proll MA; Clark RB
Mol Pharmacol; 1991 Jun; 39(6):740-4. PubMed ID: 1904981
[TBL] [Abstract][Full Text] [Related]
11. Ca2+ inhibition of beta-adrenergic receptor- and forskolin-stimulated cAMP accumulation in C6-2B rat glioma cells is independent of protein kinase C.
Debernardi MA; Munshi R; Brooker G
Mol Pharmacol; 1993 Mar; 43(3):451-8. PubMed ID: 8383803
[TBL] [Abstract][Full Text] [Related]
12. Dual coupling of cloned human 5-hydroxytryptamine1D alpha and 5-hydroxytryptamine1D beta receptors stably expressed in murine fibroblasts: inhibition of adenylate cyclase and elevation of intracellular calcium concentrations via pertussis toxin-sensitive G protein(s).
Zgombick JM; Borden LA; Cochran TL; Kucharewicz SA; Weinshank RL; Branchek TA
Mol Pharmacol; 1993 Sep; 44(3):575-82. PubMed ID: 8396718
[TBL] [Abstract][Full Text] [Related]
13. Epinephrine-induced sequestration of the beta-adrenergic receptor in cultured S49 WT and cyc- lymphoma cells.
Clark RB; Friedman J; Prashad N; Ruoho AE
J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(1):97-119. PubMed ID: 2984267
[TBL] [Abstract][Full Text] [Related]
14. Identification of protein kinase C phosphorylation sites in the angiotensin II (AT1A) receptor.
Qian H; Pipolo L; Thomas WG
Biochem J; 1999 Nov; 343 Pt 3(Pt 3):637-44. PubMed ID: 10527943
[TBL] [Abstract][Full Text] [Related]
15. Multiple phosphorylation sites are required for pathway-selective uncoupling of the 5-hydroxytryptamine1A receptor by protein kinase C.
Lembo PM; Albert PR
Mol Pharmacol; 1995 Dec; 48(6):1024-9. PubMed ID: 8848001
[TBL] [Abstract][Full Text] [Related]
16. Amplification of cyclic AMP generation reveals agonistic effects of certain beta-adrenergic antagonists.
Jasper JR; Michel MC; Insel PA
Mol Pharmacol; 1990 Jan; 37(1):44-9. PubMed ID: 1967818
[TBL] [Abstract][Full Text] [Related]
17. Ontogeny of regulatory mechanisms for beta-adrenoceptor control of rat cardiac adenylyl cyclase: targeting of G-proteins and the cyclase catalytic subunit.
Zeiders JL; Seidler FJ; Slotkin TA
J Mol Cell Cardiol; 1997 Feb; 29(2):603-15. PubMed ID: 9140819
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II type 1 receptor signals through Raf-1 by a protein kinase C-dependent, Ras-independent mechanism.
Arai H; Escobedo JA
Mol Pharmacol; 1996 Sep; 50(3):522-8. PubMed ID: 8794890
[TBL] [Abstract][Full Text] [Related]
19. Stable activation and desensitization of beta 2-adrenergic receptor stimulation of adenylyl cyclase by salmeterol: evidence for quasi-irreversible binding to an exosite.
Clark RB; Allal C; Friedman J; Johnson M; Barber R
Mol Pharmacol; 1996 Jan; 49(1):182-9. PubMed ID: 8569705
[TBL] [Abstract][Full Text] [Related]
20. mu-Opioid receptors inhibit dopamine-stimulated activity of type V adenylyl cyclase but enhance dopamine-stimulated activity of type VII adenylyl cyclase.
Yoshimura M; Ikeda H; Tabakoff B
Mol Pharmacol; 1996 Jul; 50(1):43-51. PubMed ID: 8700117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
